Transmission of leprosy: A study of skin and nasal secretions of household contacts of leprosy patients using PCR

American Journal of Tropical Medicine and Hygiene

Volumn 78, Issue 3, 2008, Pages 518-521

  Job, Charles K ^b   Jayakumar, Joseph ^b   Kearney, Michael ^a   Gillis, Thomas P ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Leprosy Center   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; HISTOPATHOLOGY; HOUSEHOLD; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MYCOBACTERIUM LEPRAE; NOSE MUCOSA; NOSE SECRETION; POLYMERASE CHAIN REACTION; SKIN SECRETION; FAMILY SIZE; MICROBIOLOGY; MUCUS; SKIN;

BACILLI (CLASS); MYCOBACTERIUM LEPRAE;

LEPROSTATIC AGENT;

FAMILY CHARACTERISTICS; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MUCUS; NASAL MUCOSA; POLYMERASE CHAIN REACTION; SKIN;

EID: 42949119688     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.78.518     Document Type: Article

References (23)

1. Fine P, 2007. Leprosy: what is being "eliminated." Bull World Health Organ 85: 2-4.
2. Meima A, Richardus JH, Habbema JD, 2004. Trends in leprosy case detection worldwide since 1985. Lepr Rev 75: 19-33.
3. Anonymous, 2006. Global leprosy situation, 2006. Wkly Epidemiol Rec 81: 309-316.
4. Job CK, Chehl S, Hastings RC, 1990. New findings on the mode of entry of M. leprae in nude mice. Int J Lepr 58: 726-729.
5. Chan PC, Reyes LM, Demerre-Lopez B, Gonzaga EM, De los Santos MFA, Gillis TP, 1997. Leprosy infection and disease in the national capital region. Philippine J Microbiol Infect Dis 26: 159-162.
6. Klatser PR, van Beers S, Madjid B, Day B, de Wit MY, 1993. Detection of Mycobacterium leprae nasal carriers in populations for which leprosy is endemic. J Clin Microbiol 31: 2947-2951.
7. Smith WC, Smith CM, Cree IA, Jadhav RS, Macdonald M, Edward VK, Oskam L, van Beers S, Klatser P, 2004. An approach to understanding the transmission of Mycobacterium leprae using molecular and immunological methods: results from the MILEP2 study. Int J Lepr Other Mycobact Dis 72: 269-277.
8. Chatterjee BR, 1976. Carrier state in leprosy. Lepr India 48: 643-644.
9. Abraham S, Mozhi NM, Joseph GA, Kurian N, Rao PS, Job CK, 1998. Epidemiological significance of first skin lesion in leprosy. Int J Lepr Other Mycobact Dis 66: 131-139.
10. Williams DL, Gillis TP, Booth RJ, Looker D, Watson JD, 1990. The use of a specific DNA probe and polymerase chain reaction for the detection of Mycobacterium leprae. J Infect Dis 162: 193-200.
11. Williams DL, Gillis TP, Fiallo P, Job CK, Gelber RH, Hill C, Izumi S, 1992. Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. Mol Cell Probes 6: 401-410.
12. Pedley JC, 1970. Summary of the results of a search of the skin surface for Mycobacterium leprae. Lepr Rev 41: 167-168.
13. Hosokawa A, 1999. A clinical and bacteriological examination of Mycobacterium leprae in the epidermis and cutaneous appendages of patients with multibacillary leprosy. J Dermatol 26: 479-488.
14. Hatta M, Van Beers SM, Madjid B, Djumadi A, de Wit MY, Klatser PR, 1995. Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia. Trans R Soc Trop Med Hyg 89: 381-385.
15. Gelber RH, Humphres RC, Fieldsteel AH, 1986. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone. Int J Lepr Other Mycobact Dis 54: 273-283.
16. Fieldsteel AH, Levy L, 1976. Neonatally thymectomized Lewis rats infected with Mycobacterium leprae: response to primary infection, secondary challenge, and large inocula, Infect Immun 14: 736-741.
17. Wakade AV, Shetty VP, 2006. Isolation of Mycobacterium leprae from untreated borderline tuberculoid, mid-borderline and in-determinate cases using the mouse foot pad technique - a study of 209 cases. Lepr Rev 77: 366-370.
18. Franzblau SG, Chan GP, Garcia-Ignacio BG, Chavez VE, Livelo JB, Jimenez CL, Parrilla ML, Calvo RF, Williams DL, Gillis T, 1994. Clinical trial of fusidic acid for lepromatous leprosy. Antimicrob Agents Chemother 38: 1651-1654.
19. Levy L, Shepard CC, Fasal P, 1976. The bactericidal effect of rifampicin on M. leprae in man: a) single doses of 600, 900 and 1200 mg; and b) daily doses of 300 mg. Int J Lepr Other Mycobact Dis 44: 183-187.
20. Anonymous, 1997. Action Program for the Elimination of Leprosy: Status Report. Geneva: World Health Organization.
21. Sehgal VN, Rege VL, Vadiraj SN, 1970. Inoculation leprosy subsequent to small-pox vaccination. Dermatologica 141: 393-396.
22. Sehgal VN, 1971. Inoculation leprosy appearing after seven years of tattooing. Dermatologica 142: 58-61.
23. Seghal VN, 1986. Leprosy following mechanical trauma. Lepr Rev 57: 272.